How to remotely upgrade to the MiniMed™ 780G system

Man remotely upgrading to the MiniMed™ 780G system

Medtronic received FDA approval for the Remote Software Upgrade and Medtronic Diabetes Updater App
 

It’s no secret that the MiniMed™ 780G system is now FDA approved in the U.S. The great news doesn’t stop there! We are pleased to announce that we also received approval for the Remote Software Upgrade and Medtronic Diabetes Updater App. Current users of the MiniMed™ 770G system can now rejoice and get access to the latest MiniMed™ 780G system technology through a no-cost remote software update – without switching your physical pump! 

Visit the MiniMed™ 780G system page if you haven’t yet learned about all the exciting new features and benefits it has to offer. Here we’ll tell what the MiniMed™ 780G software upgrade is, who qualifies, and answers to all your other burning questions.  

 

Medtronic software upgrade
 

The MiniMed™ 780G system uses the same pump as the MiniMed™ 770G system but runs with a smarter more advanced software. This means if you’re currently using a MiniMed™ 770G insulin pump, then you can upgrade to the latest technology over Wi-Fi using your Bluetooth®-enabled MiniMed™ 770G pump and the Diabetes Updater App on your compatible smartphone.* You’re probably a pro at navigating your MiniMed™ 770G pump so no need to worry about learning a new device. Of course, if you need any extra help, our team is always happy to assist!

mobile phone with updater app

Top questions about remote software upgrades
 

What is the Medtronic Diabetes Updater App?

Medtronic Diabetes Updater app icon

The Medtronic Diabetes Updater app uses your smartphone to give you access to the latest insulin pump software technology. The Updater App connects to the MiniMed™ 770G pump via Bluetooth® to wirelessly upgrade the software. Available in the Google Play™ and Apple AppStore® online stores.
 

How can I upgrade to the MiniMed™ 780G system?

For MiniMed™ 770G system users, please follow these steps to upgrade:

1. Request a software upgrade and compatible CGM sensor on Diabets.shop.

2. Obtain a prescription from your healthcare provider. Medtronic can work with you if needed.

3. Receive your Software Upgrade Kit.

4. Complete the online training.

5. Download Medtronic Diabetes Updater App and perform the update.
 

Are there any technical requirements for the Updater App?

A compatible mobile phone and internet connection are required. The app is compatible with major smartphone brands and operating systems, see complete list of compatible devices

The Updater App is available in the Google Play™ and Apple AppStore® .
 

Could I choose to go back to the MiniMed™ 770G system after I’ve completed the software upgrade process?

You cannot revert to the old software after completion of the software upgrade process on the pump.   

 

Have more questions? Drop them in the comments or visit our website for more information. If you plan on upgrading, show us what you’re doing while you wait for the system to upgrade by tagging us on social media @MedtronicDiabetes!    

 

 

*Check phone compatibility.
 
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
 
Software Upgrade Terms and Conditions:
  • This program allows MiniMed™ 770G system users a software upgrade at no charge until April 27, 2024.
  • Software upgrade process is subject to change. The process may result in healthcare provider office visit and may result in out-of-pocket expenses such as co-pay, depending on insurance coverage. The process may require the completion of product related training.
  • This program includes the insulin pump software only. CGM products and consumables are not included in this offer.
  • Warranty dates do not reset. The replacement warranty date of an insulin pump upgraded with the software will remain the same as the replacement warranty date of the initial pump purchased. Your warranty date does not impact eligibility for a software update.
  • MiniMed™ pumps and software have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider regarding your eligibility to receive the software upgrade based on the labeling of the upgrade, which may differ from the labeling of the MiniMed™ 770G pump.
  • Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
  • A valid prescription will be required for this software upgrade. All participants should consult their healthcare provider for all therapy related decisions.
  • Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.
 
Important Safety Information: Medtronic Diabetes Updater app
The Medtronic Diabetes Updater app is intended for use on a suitable consumer electronic device to wirelessly update software of a MiniMed™ insulin pump with smart device connectivity. The Medtronic Diabetes Updater app is not intended to analyze or modify the continuous glucose monitor data or insulin pump data, nor is it intended to control any function of the connected continuous glucose monitoring system or insulin pump. The Medtronic Diabetes Updater app is not intended to receive information directly from the sensor or transmitter of a continuous glucose monitoring system. The Medtronic Diabetes Updater app is not intended to be used without a CareLink™ account. Log into an existing CareLink™ account or create a new account during the update process.
 
MiniMed 780G system with SmartGuard technology with Guardian 4 Sensor
The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G System includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. 
The Medtronic MiniMed 780G System consists of the following devices: MiniMed 780G Insulin Pump, the Guardian 4 Transmitter, the Guardian 4 Sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide Test Strips. The system requires a prescription from a healthcare professional.
 The Guardian 4 Sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian (4) sensor is indicated for up to seven days of continuous use. 
The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.
 
WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.

 

MiniMed 770G system with SmartGuard technology

The MiniMed 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 770G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. 

The Medtronic MiniMed 770G System consists of the following devices: MiniMed 770G Insulin Pump, the Guardian Link (3) Transmitter, the Guardian Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide Test Strips. The system requires a prescription. 

The Guardian Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. 

All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian Sensor (3). All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard Auto Mode for people who require less than eight units or more than 250 units of total daily insulin per day. A total daily dose of at least eight units, but no more than 250 units, is required to operate in SmartGuard Auto Mode.

 

WARNING: Do not use the MiniMed 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

 

Related Articles

About Author